Surgery – Blood drawn and replaced or treated and returned to body – Constituent removed from blood and remainder returned to body
Reexamination Certificate
2000-05-25
2003-12-16
Sykes, Angela D. (Department: 3762)
Surgery
Blood drawn and replaced or treated and returned to body
Constituent removed from blood and remainder returned to body
C604S005010, C604S006060, C210S645000
Reexamination Certificate
active
06663585
ABSTRACT:
The present invention relates to a method of monitoring vascular access during an extracorporeal blood treatment, in particular a dialysis or a blood separation treatment, and also relates to a device for extracorporeal blood treatment, in particular a dialysis or blood separation treatment, used for monitoring a vascular access.
DESCRIPTION OF RELATED ART
To remove substances that are normally eliminated in the urine, the blood of a kidney disease patient is passed through a chamber of a dialyzer which is subdivided by a semipermeable membrane into two chambers in an extracorporeal blood circulation system. Dialysis fluid flows through the other chamber. An arteriovenous fistula is often created for access to the vascular system, but an implant may also be used. Blood is taken from the patient through an arterial needle connected to the arterial blood line of the extracorporeal blood circulation loop, and then it is supplied back to the patient again through a venous needle connected to the venous blood line.
Cell separators, where a donor's blood is subjected to density centrifugation in an extracorporeal circulation and thereby separated into its constituents, are used to extract blood components needed for treating patients who have certain diseases.
For the safety of the patient during an extracorporeal blood treatment such as dialysis or a blood separation treatment, it is extremely important for the vascular access to be monitored. For example, if the venous needle slips out, the patient may suffer a major blood loss if this condition is not detected immediately.
Safety systems for monitoring a vascular access are known from the field of infusion technology. European Patent Application 328,162 A describes an infusion device having a pressure transducer in the infusion line for detecting the patient's heart rate as long as the needle has access to the vascular system. A defective vascular access is detected by the fact that the heart rate is no longer measured as pressure pulses in the infusion line.
European Patent Application 328 163 A describes an infusion device where the pressure pulses generated by the infusion pump in the infusion line are monitored. If a needle slips out, it is detected by a change in the shape of the pressure pulses.
Such safety systems are also used in dialysis machines. A known dialysis machine having a device for monitoring the vascular access has a pressure transducer arranged in the venous blood line. The pressure transducer detects a pressure drop that occurs when a needle slips out. However, a study of venous pressure monitoring with dialysis machines has shown the possibility of failure of a safety system based on monitoring the venous return pressure, when used to detect blood loss into the environment if a needle slips out.
International Patent WO97/10013 describes a dialysis machine having a monitoring system where pressure pulses generated by the blood pump in the arterial blood line are monitored in the venous blood line.
European Patent Application 745 400 A describes a device for monitoring the occlusive position of a peristaltic pump into which is inserted a length of tubing. With the known device, a conductor loop is created by a shunt. The shunt is an electric connection between the section of the length of tubing upstream from the pump rolls and the section downstream from the pump rolls. To monitor the occlusive position, an electric current is induced in the conductor loop with a field coil arranged upstream from the pump rolls on the length of tubing and is monitored with an induction coil arranged downstream from the pump roll. The occlusive position of the peristaltic pump is deduced from the amperage of the current flowing in the conductor loop.
SUMMARY OF THE INVENTION
The object of the present invention is to create a method of monitoring vascular access during an extracorporeal blood treatment in such a way as to permit detection of a defective vascular access with a high reliability, without requiring extensive modifications in the blood treatment equipment.
Another object of the present invention is to create a device for extracorporeal blood treatment that can detect a defective vascular access with a high reliability, and can be implemented with relatively simple technical means.
In one aspect, the invention is a method of monitoring a vascular access during an extracorporeal blood treatment, comprising the steps of flowing blood taken from a patient's vascular system through an arterial blood line of an extracorporeal blood circulation loop into a blood treatment machine, flowing blood out of the blood treatment machine back into the patient's vascular system through a venous blood line of the extracorporeal blood circulation loop thus forming a conductor loop, inducing an electric current flow in a connection of the extracorporeal blood circulation loop with the patient's vascular system, measuring a current flowing in the conductor; and determining the vascular access is defective when a characteristic change in the electric current is detected.
In another aspect, the invention is a device for extracorporeal blood treatment with an extracorporeal circulation loop, having a blood treatment machine, an arterial blood line connectable at one end to a patient's vascular system and at another end to an inlet of the blood treatment machine, and a venous blood line connectable at one end to an outlet of the blood treatment machine and at the other end to the vascular system of the patient, and a device for monitoring vascular access. The device for monitoring vascular access comprises means for inducing an electric current flow in a connection of the extracorporeal circulation loop with the patient's vascular system disposed at a first location, means for measuring the induced electric current disposed at a second location in the extracorporeal circulation loop, said second location being different the first location, and an analyzer unit to determine if the vascular access is defective by monitoring a characteristic change in the induced electric current. The blood treatment machine, the arterial blood line, the venous blood line and the patient's vascular system form a closed conductor loop.
It has surprisingly been found that the extracorporeal blood circulation, which includes the arterial vascular access, the arterial blood line, the blood treatment device, the venous blood line, the venous vascular access and the connecting vascular system of the patient or donor, forms a closed conductor loop in which an electric current can flow. Measurements have shown that the circuit is not interrupted to a sufficient extent by the blood pump connected to the extracorporeal circuit, which may also be designed as an occluding roller pump, nor by a drip chamber connected to the venous blood line.
With the method and the device according to the present invention, an electric current flow is induced in the closed conductor loop, with the current flowing in the conductor loop being measured and a defective vascular access being deduced when there is a characteristic change in amperage. A faulty vascular access is found when the circuit is interrupted, i.e. when the venous or arterial needle of the blood line has slipped out.
The impedance can be preferably measured with an alternating current whose amplitude and frequency are selected so that there can be no risk to the patient or donor, nor any damage to the blood, while on the other hand permitting signal analysis with a high reliability.
The method and device according to the present invention for monitoring a vascular access, can be used to advantage with all blood treatment methods using an extracorporeal blood circulation. These include, for example, dialysis methods or methods for separating blood into individual blood constituents. A blood treatment device as a component of a device for treating blood is understood to include, for example, a dialyzer, a filter or a separation unit of a cell separator.
To avoid intervention into th
Deak Leslie
Fresenius Medical Care Deutschland GmbH
Kenyon & Kenyon
Sykes Angela D.
LandOfFree
Method and device for monitoring vessel access during... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and device for monitoring vessel access during..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and device for monitoring vessel access during... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3115041